Brokerages Set Ryan Specialty Holdings, Inc. (NYSE:RYAN) PT at $71.67

Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) has earned a consensus recommendation of "Hold" from the eleven research firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $71.67.

Several equities analysts recently weighed in on the company. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research note on Thursday, November 21st. UBS Group upped their target price on Ryan Specialty from $67.00 to $76.00 and gave the stock a "buy" rating in a research note on Tuesday, August 13th. Wells Fargo & Company lifted their price target on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a research note on Thursday, October 10th. BMO Capital Markets upgraded shares of Ryan Specialty from a "market perform" rating to an "outperform" rating and upped their price objective for the stock from $65.00 to $75.00 in a research report on Tuesday, September 24th. Finally, Bank of America increased their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a report on Thursday, October 10th.

Ryan Specialty Stock Performance

NYSE:RYAN traded up $0.31 during trading hours on Friday, reaching $75.40. The company had a trading volume of 433,476 shares, compared to its average volume of 869,154. The firm has a market cap of $19.74 billion, a PE ratio of 97.92, a price-to-earnings-growth ratio of 1.70 and a beta of 0.62. Ryan Specialty has a 1-year low of $41.49 and a 1-year high of $75.97. The business's 50 day moving average price is $69.99 and its 200-day moving average price is $63.12. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, meeting the consensus estimate of $0.41. The company had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The firm's revenue was up 20.5% on a year-over-year basis. During the same quarter last year, the business earned $0.32 earnings per share. Research analysts forecast that Ryan Specialty will post 1.8 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were paid a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date of this dividend was Tuesday, November 12th. Ryan Specialty's dividend payout ratio (DPR) is 57.14%.

Insider Activity

In other news, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the sale, the director now owns 78,149 shares of the company's stock, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the transaction, the executive vice president now owns 12,386 shares of the company's stock, valued at $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 11.10% of the company's stock.

Hedge Funds Weigh In On Ryan Specialty

A number of hedge funds have recently modified their holdings of the business. Hollencrest Capital Management purchased a new position in Ryan Specialty during the third quarter worth about $25,000. Assetmark Inc. purchased a new stake in Ryan Specialty in the third quarter valued at approximately $34,000. GAMMA Investing LLC lifted its stake in Ryan Specialty by 96.4% during the second quarter. GAMMA Investing LLC now owns 605 shares of the company's stock worth $35,000 after purchasing an additional 297 shares in the last quarter. Crewe Advisors LLC purchased a new position in shares of Ryan Specialty during the second quarter worth $39,000. Finally, Quarry LP grew its stake in shares of Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after buying an additional 422 shares in the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.